{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T09:28:47Z","timestamp":1725182927215},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,7,23]],"date-time":"2007-07-23T00:00:00Z","timestamp":1185148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>Erythropoietin (EPO) is a hormone regulating the proliferation and differentiation of erythroid precursor cells. The hypothesis that haematopoietic and endothelial cells share a common haemanglioblast progenitor among others is based on the finding that both cell lineages express cell surface antigens, such as CD31 and CD34.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In the present study, we investigated the angiogenic potential of recombinant human erythropoietin on cyclosporine A (CsA)\u2010induced nephrotoxicity in the rat kidney and compared it with the effect of basic fibroblast growth factor (bFGF), a well\u2010known angiogenic factor.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Rats were divided into five groups: A (control), B (EPO treated), C (CsA treated), D (CsA\u00a0+\u00a0EPO treated) and E (CsA\u00a0+\u00a0bFGF treated). Mouse anti\u2010human CD31 and CD34 antibodies were used to evaluate the kidney vessels present in histological preparations.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Glomerular and peritubular capillaries in Group B (EPO) were increased compared with the control (Group A; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Reduction of the same kidney vessels (glomerular and peritubular capillaries) in Group C (CsA; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) compared with controls was observed, whereas in Groups D (CsA\u00a0+\u00a0EPO treated) and E (CsA\u00a0+\u00a0bFGF treated), capillaries were increased compared with Group C (CsA; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Erythropoietin has a significant angiogenic effect in rat kidney with CsA\u2010induced nephrotoxicity, similar to the effect of the other angiogenic factor bFGF.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04670.x","type":"journal-article","created":{"date-parts":[[2007,7,23]],"date-time":"2007-07-23T13:01:29Z","timestamp":1185195689000},"page":"866-869","source":"Crossref","is-referenced-by-count":14,"title":["ERYTHROPOIETIN ENHANCES ANGIOGENESIS IN AN EXPERIMENTAL CYCLOSPORINE A\u2010INDUCED NEPHROTOXICITY MODEL IN THE RAT"],"prefix":"10.1111","volume":"34","author":[{"given":"Anna","family":"Efthimiadou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pagonopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lambropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos K","family":"Nikolettos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,23]]},"reference":[{"issue":"6","key":"e_1_2_5_2_2","first-page":"S3","article-title":"Biology of erythropoietin","volume":"72","author":"Jelkmann W.","year":"1994","journal-title":"Clin. Invest"},{"key":"e_1_2_5_3_2","first-page":"3974","article-title":"Erythropoietin receptor mRNA expression in human endothelial cells.","volume":"91","author":"Anagnostou A","year":"1994","journal-title":"Proc"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199801000-00007"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod60.4.861"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01245.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a proangiogenic phenotype in cultured endothelia cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti D","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_8_2","first-page":"5","article-title":"Cyclosporine: The agent and its actions","volume":"17","author":"Kahan BD","year":"1985","journal-title":"Transplant. Proc"},{"key":"e_1_2_5_9_2","first-page":"145","article-title":"Cyclosporine nephrotoxicity: Studies in laboratory animals","volume":"17","author":"Sulivan BA","year":"1985","journal-title":"Transplant. Proc"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198702000-00023"},{"key":"e_1_2_5_11_2","first-page":"3133","article-title":"FK506 mechanism of nephrotoxicity: Stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro","volume":"23","author":"Moutabarrid A","year":"1991","journal-title":"Transplant. Proc"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90610-I"},{"key":"e_1_2_5_13_2","first-page":"104","article-title":"Morphologic diagnosis of cyclosporine nephrotoxicity","volume":"5","author":"Mihatsch MJ","year":"1988","journal-title":"Semin. Diagn. Pathol"},{"key":"e_1_2_5_14_2","first-page":"265","article-title":"The role of basic\u2010fibroblast growth factor (b\u2010FGF) in cyclosporine\u2010induced nephrotoxicity","volume":"20","author":"Efthimiadou A","year":"2006","journal-title":"In Vivo"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.165"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060003847.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.113"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780056"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000135059.67385.5D"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.15.5978"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01269.2004"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000206468.18653.EC"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055003808.x"},{"key":"e_1_2_5_24_2","first-page":"372","article-title":"Angiocidal effect of cyclosporin A: A new therapeutic approach for pathogenic angiogenesis","volume":"24","author":"Wilasrusmee C","year":"2005","journal-title":"Int. Angiol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.5.607"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084275"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00781.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00637.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004410050635"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00621.x"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04670.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04670.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:39:35Z","timestamp":1696963175000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04670.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,23]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04670.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04670.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,23]]}}}